Roche
Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of in vitro diagnostics and a global supplier of transformative, innovative solutions across major disease areas. They are a global pioneer in pharmaceuticals and diagnostics, focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Latest Content
Article
Applications of Liquid Biopsy in Cancer and Beyond
Liquid biopsies are becoming an increasingly important tool for the early detection, prognosis and monitoring of treatment outcomes in cancer, and hold the promise of transforming the management of other diseases in the future.
News
Bioprinted Patches Repair Damaged Heart Tissue
A new technology that uses bioprinted patches to repair damaged heart tissue has been proven to be safer and more cost-effective for patients.
Product News
Pistoia Alliance Launches Pharma Innovation Council and Appoints New Chief Portfolio Officer
The Pistoia Alliance has launched the Pistoia Alliance Pharma Innovation Council. The Council will seed ideas for new pre-competitive projects aligned with the Alliance’s strategic themes: Emerging sciences and Technology, Improving the Efficiency and Effectiveness of R&D and Empowering the Patient.
Industry Insight
Basel: Europe’s Booming Biotech Powerhouse
This article spotlights the driving forces behind Basel’s snowballing reputation, and notes some of the success stories arising from this innovative biotech powerhouse.
Article
Data Reporting, Integrity and Compliance
In this article, we examine how analytical scientists can enhance their data sharing and reporting practices, leading to improvements in data integrity and an easier route to compliance within a regulated good manufacturing practice (GMP) environment.
Product News
Qnovia, Inc. Raises $17 Million in Series A Funding To Advance Its Inhalable Therapeutics Pipeline
Qnovia, Inc., a pharma company developing inhaled therapeutics with an initial focus on nicotine replacement therapy and cardiopulmonary diseases, has announced it has raised $17 million in Series A funding.
Industry Insight
“Rewriting the Textbook” for Precision Medicine
Technology Networks recently had the pleasure of speaking with Mark Fidock, vice president for Diagnostic Development, Precision Medicine at AstraZeneca, to find out how the company is “rising to the challenge” of delivering precision medicines for chronic diseases.
Product News
PhoreMost Enters Multi-Project Drug Target Discovery Collaboration With Roche
PhoreMost Ltd. today announced it has entered into a multi-project target discovery collaboration with Roche.
Product News
Medix Biochemica Appoints Dr. Michele Pedrocchi to Its Board of Directors
Medix Biochemica has announced the appointment of Dr. Michele Pedrocchi to their Board of Directors.
News
Key to Hepatitis A Replication Discovered
Scientists have discovered how a protein and enzymes interact to allow hepatitis A virus to replicate, and then used a known drug to stop viral replication in an animal model.
Advertisement
